News

So klein und schon so böse: Eingefärbte Tumore verraten frühzeitig ihren schlechten Einfluss

contextflow announces mid-seven figures Series A Investment

B&C investiert in österreichisches Tech-Unternehmen contextflow

APEIRON Biologics Announces Changes to Management and Supervisory Boards

Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHARMIG mit neuem Legal Counsel

One machine as a one-stop source for respiration valves and sample racks

Scientists develop “scifi-RNA-seq” method for ultra-high-throughput RNA sequencing in single cells

AUSTROMED: Labordiagnostik muss nachhaltig im Gesundheitssystem verankert werden

DNA-based material with tunable properties

Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform

Blood test detects childhood tumors based on their epigenetic profiles

Forschungs-Update zum Welt-Multiple-Sklerose-Tag Forscher*innen widmen sich „verborgenen“ Symptomen der MS

Lexogen gains ISO 9001:2015 quality management certification

27 MAY 2021 POSITIVE PHASE 1 RESULTS WITH IMMUNOTHERAPIES TARGETING PCSK9 TO TREAT HYPERCHOLESTEROLEMIA PUBLISHED BY THE EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform

Hilfe für PatientInnen mit Multipler Sklerose

Österreichischer Gründerpreis PHÖNIX: Die besten Start-ups, Spin-offs, Prototypen und Female Entrepreneurs werden gesucht